InsidersTradesSigma
Follow the 基蛋生物 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 基蛋生物 has logged 3 insider filings. Market capitalisation: €4.2bn. The latest transaction was reported on 15 August 2025 (Sale). Among the most active insiders: 南京爱基商务信息咨询有限公司. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
基蛋生物 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of medical diagnostics.